Streetbeat News

SNDL

SNDL Inc.

https://www.sndlgroup.com

Industry

Drug Manufacturers - Specialty & Generic

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

Open

1.97

Mkt cap

518M

Volume

1.5M

High

1.98

P/E Ratio

-6.50

52-wk high

2.93

Low

1.94

Div yield

N/A

52-wk low

1.30

A Democratic senator questioned Attorney General Merrick Garland on the impact of the SAFER Banking Act's Section 10 on criminal investigations, highlighting concerns about notifying customers of account terminations due to investigations. The section, criticized for potentially compromising law enforcement, was revised after bipartisan negotiations. The bill aims to mitigate financial discrimination against industries like gun manufacturing and payday lending. The discussion reflects ongoing debates over cannabis policy and banking regulations, with the Justice Department and DEA reviewing cannabis scheduling.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 5:12 pm

Marijuana stocks experienced a bearish Monday, with notable movements among both gainers and losers. Target Group, Greenlane Holdings, and Mexco Energy were among the top gainers, while AusCann Group Holdings led the losers with a significant drop. The market saw a wide range of performance, highlighting the volatility within the cannabis sector.

Portfolio Pulse from Benzinga Insights

April 15, 2024 | 8:30 pm

Marijuana companies, led by Verano Holdings Corp., Canna Provisions, Wiseacre Farm, and Treevit CEO Gyasi Sellers, are challenging the DOJ's enforcement of cannabis prohibition, arguing it infringes on state rights. They request oral arguments in a Massachusetts federal court to address constitutional questions and the DOJ's stance that cannabis legalization promotes 'tourism' justifying federal prohibition. The case, supported by law firms Boies Schiller and Flexner LLP and Lesser, Newman, Aleo and Nasser LLP, highlights the conflict between state-legal cannabis activities and federal enforcement under the Controlled Substances Act.

Portfolio Pulse from Benzinga Newsdesk

April 15, 2024 | 7:26 pm

Cannabis stocks experienced significant movements on April 12, 2024, with notable gainers including Indiva, Belgravia Hartford Cap, and Maple Leaf Green World, among others. Conversely, Global Hemp Group led the losers, followed by Elixinol Wellness and cbdMD. The fluctuations reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 8:30 pm

The FDA Commissioner stated there's 'no reason for the DEA to delay' the rescheduling of marijuana, indicating a potential shift in federal policy that could significantly impact the regulatory landscape for cannabis companies. This statement was made during a congressional hearing on hemp regulatory issues, suggesting a more favorable federal stance towards cannabis regulation.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 6:14 pm

Cannabis stocks experienced significant movements on April 9, 2024, with notable gainers including Target Group, iAnthus Capital Holdings, and Greenlane Holdings, among others. Conversely, GreenGro Technologies led the losers, followed by Heritage Cannabis Holding and Elixinol Wellness. The volatility reflects ongoing market adjustments within the cannabis sector.

Portfolio Pulse from Benzinga Insights

April 09, 2024 | 8:30 pm

Cannabis stocks are trading lower, influenced by Tilray's worse-than-expected Q3 results.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:31 am

Canadian cannabis stocks like Tilray, Canopy, Aurora, and others are rallying due to recent developments such as Tilray's earnings, Organigram's investor day, and movements by Canopy and Aurora. Legislative changes in Canada, Germany, and the U.S. have positively impacted these stocks. Analyst Pablo Zuanic highlights the sector's potential for growth despite liquidity issues, with some stocks trading as proxies for U.S. exposure. Aurora, Tilray, and Canopy show significant short interest, with Tilray and SNDL leading in revenue. Strategic partnerships and international operations are crucial for expansion.

Portfolio Pulse from Nicolás Jose Rodriguez

April 08, 2024 | 10:34 pm

The cannabis sector experienced significant movement on April 5, 2024, with numerous companies seeing substantial gains or losses in their stock prices. Notably, MPX International and 22nd Century Group were among the top gainers, while Choom Holdings and Heritage Cannabis Holding faced steep declines.

Portfolio Pulse from Benzinga Insights

April 05, 2024 | 8:30 pm

Cannabis stocks experienced significant movements on April 4, 2024, with notable gainers including Choom Holdings, Target Group, and Heritage Cannabis Holding. Conversely, CNBX Pharmaceuticals and Global Compliance led the losers. The volatility reflects ongoing market adjustments within the cannabis sector.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.